Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 11UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 3Thymoma 1Small Cell Lung Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Esophageal Squamous Cell Carcinoma 1

Interventions

spartalizumab 2tislelizumab 1pegaspargase 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Lymphoma, Extranodal NK-T-Cell × Radiotherapy × Clear all
NCT05149170 2021-12-08

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

ChineseAMS

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡